Nonetheless, K-562 (CML) and Jurkat (T-ALL) lines subjected to RNF5 KD do not exhibit growth inhibition or undergo cell death, while similarly treated AML lines do. This evidence concerns the gene RNF5 and acute lymphoblastic leukemia.